BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aryal S, Nathan SD. An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on Emerging Drugs 2018;23:159-72. [DOI: 10.1080/14728214.2018.1471465] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhou P, Cao Z, Liu Y, Guo T, Yang R, Wang M, Ren X, Wu L, Sun L, Peng C, Wang C, Zhang J. Co-achievement of enhanced absorption and elongated retention of insoluble drug in lungs for inhalation therapy of pulmonary fibrosis. Powder Technology 2022;407:117679. [DOI: 10.1016/j.powtec.2022.117679] [Reference Citation Analysis]
2 Sehgal M, Jakhete S, Manekar A, Sasikumar S. Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e09773] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Zhang Y, Lu P, Qin H, Zhang Y, Sun X, Song X, Liu J, Peng H, Liu Y, Nwafor EO, Li J, Liu Z. Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential. Biomed Pharmacother 2021;133:111072. [PMID: 33378971 DOI: 10.1016/j.biopha.2020.111072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cox IA, Borchers Arriagada N, de Graaff B, Corte TJ, Glaspole I, Lartey S, Walters EH, Palmer AJ. Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Eur Respir Rev 2020;29:200154. [PMID: 33153990 DOI: 10.1183/16000617.0154-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zhang T, Gao Y, Xiao D, Zhu J, Zhou M, Li S, Zhang M, Lin Y, Cai X. Nucleic acid based tetrahedral framework DNA nanostructures for fibrotic diseases therapy. Applied Materials Today 2020;20:100725. [DOI: 10.1016/j.apmt.2020.100725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Feng L, Li W, Chao Y, Huan Q, Lu F, Yi W, Jun W, Binbin C, Na L, Shougang Z. Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy. Kidney Dis (Basel) 2021;7:34-49. [PMID: 33614732 DOI: 10.1159/000509670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
7 Mazumder S, Barman M, Bandyopadhyay U, Bindu S. Sirtuins as endogenous regulators of lung fibrosis: A current perspective. Life Sci 2020;258:118201. [PMID: 32781070 DOI: 10.1016/j.lfs.2020.118201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mammarappallil JG, Rankine L, Wild JM, Driehuys B. New Developments in Imaging Idiopathic Pulmonary Fibrosis With Hyperpolarized Xenon Magnetic Resonance Imaging. J Thorac Imaging 2019;34:136-50. [PMID: 30801449 DOI: 10.1097/RTI.0000000000000392] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
9 de Brito AA, da Silveira EC, Rigonato-Oliveira NC, Soares SS, Brandao-Rangel MAR, Soares CR, Santos TG, Alves CE, Herculano KZ, Vieira RP, Lino-Dos-Santos-Franco A, Albertini R, Aimbire F, de Oliveira AP. Low-level laser therapy attenuates lung inflammation and airway remodeling in a murine model of idiopathic pulmonary fibrosis: Relevance to cytokines secretion from lung structural cells. J Photochem Photobiol B 2020;203:111731. [PMID: 31935633 DOI: 10.1016/j.jphotobiol.2019.111731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
10 Assad N, Sood A, Campen MJ, Zychowski KE. Metal-Induced Pulmonary Fibrosis. Curr Environ Health Rep 2018;5:486-98. [PMID: 30298344 DOI: 10.1007/s40572-018-0219-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
11 Marcos Ribes B, Sancho-Chust JN, Talens A, Arlandis M, Herraiz P, Chiner E, Aznar T. Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis. Eur J Hosp Pharm 2020;27:350-4. [PMID: 33020058 DOI: 10.1136/ejhpharm-2018-001806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mamazhakypov A, Schermuly RT, Schaefer L, Wygrecka M. Lipids - two sides of the same coin in lung fibrosis. Cell Signal 2019;60:65-80. [PMID: 30998969 DOI: 10.1016/j.cellsig.2019.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
13 Barnes T, Brown KK, Corcoran B, Glassberg MK, Kervitsky DJ, Limper AH, McGuire K, Williams K, Roman J; Comparative Biology of Pulmonary Fibrosis Group. Research in Pulmonary Fibrosis Across Species: Unleashing Discovery Through Comparative Biology. Am J Med Sci 2019;357:399-404. [PMID: 30879739 DOI: 10.1016/j.amjms.2019.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]